{
    "organizations": [],
    "uuid": "3a01df9095b5b6867514113d113eecd48cff9217",
    "author": "",
    "url": "https://www.reuters.com/article/brief-evoke-announces-agreement-with-mal/brief-evoke-announces-agreement-with-mallinckrodt-to-amend-milestone-payments-idUSASC09TKW",
    "ord_in_thread": 0,
    "title": "BRIEF-Evoke Announces Agreement With Mallinckrodt To Amend Milestone Payments",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26, 2018 / 11:41 AM / Updated 10 minutes ago BRIEF-Evoke Announces Agreement With Mallinckrodt To Amend Milestone Payments Reuters Staff March 26 (Reuters) - Evoke Pharma Inc: * EVOKE ANNOUNCES AGREEMENT WITH MALLINCKRODT TO AMEND MILESTONE PAYMENTS * ‍HAS AMENDED CO’S AGREEMENT WITH MALLINCKRODT, ARD INC. TO DEFER DEVELOPMENT AND APPROVAL MILESTONE PAYMENTS FOR GIMOTI​ * AMENDED AGREEMENT DEFERS AMOUNT AND TIMING OF TWO MILESTONE PAYMENTS​ * ‍AMENDED AGREEMENT DEFERS AMOUNT AND TIMING OF TWO MILESTONE PAYMENTS DUE UPON U.S. FDA ACCEPTANCE FOR REVIEW OF NEW DRUG APPLICATION​ * EVOKE PHARMA - HAVE IMPROVED CASH RUNWAY TO JANUARY OF NEXT YEAR AND REMAIN ON TRACK TO SUBMIT GIMOTI NDA NEXT QUARTER Source text for Eikon: Further company coverage:",
    "published": "2018-03-26T14:40:00.000+03:00",
    "crawled": "2018-03-26T14:52:56.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "updated",
        "minute",
        "ago",
        "announces",
        "agreement",
        "mallinckrodt",
        "amend",
        "milestone",
        "payment",
        "reuters",
        "staff",
        "march",
        "reuters",
        "evoke",
        "pharma",
        "inc",
        "evoke",
        "announces",
        "agreement",
        "mallinckrodt",
        "amend",
        "milestone",
        "payment",
        "amended",
        "co",
        "agreement",
        "mallinckrodt",
        "ard",
        "defer",
        "development",
        "approval",
        "milestone",
        "payment",
        "amended",
        "agreement",
        "defers",
        "amount",
        "timing",
        "two",
        "milestone",
        "agreement",
        "defers",
        "amount",
        "timing",
        "two",
        "milestone",
        "payment",
        "due",
        "upon",
        "fda",
        "acceptance",
        "review",
        "new",
        "drug",
        "evoke",
        "pharma",
        "improved",
        "cash",
        "runway",
        "january",
        "next",
        "year",
        "remain",
        "track",
        "submit",
        "gimoti",
        "nda",
        "next",
        "quarter",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}